Terms: = Breast cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL AND Treatment
64 results:
1. A Multifunctional liposome for Synergistic Chemotherapy with Ferroptosis Activation of Triple-Negative breast cancer.
Chai J; Hu J; Wang T; Bao X; Luan J; Wang Y
Mol Pharm; 2024 Feb; 21(2):781-790. PubMed ID: 38153044
[TBL] [Abstract] [Full Text] [Related]
2. α-Tocopherol Polyethylene Glycol 1000 Succinate-Based Cationic liposome for the Intracellular Delivery of Doxorubicin in MDA-MB-231 Triple-Negative breast cancer Cell Line.
Sandal P; Patel P; Singh D; Gupta GD; Kurmi BD
Assay Drug Dev Technol; 2023; 21(8):345-356. PubMed ID: 38010987
[No Abstract] [Full Text] [Related]
3. Alendronate Pt
Sun K; Yuan L; Chen S; Sun Y; Wei D
Adv Healthc Mater; 2024 Mar; 13(7):e2302746. PubMed ID: 37988194
[TBL] [Abstract] [Full Text] [Related]
4. Chloroprocaine antagonizes progression of breast cancer by regulating LINC00494/miR-3619-5p/MED19 axis.
Chen C; Wang N; Huang T; Cheng G; Hu Y; Wang B; Zhang Y; Wang C
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23524. PubMed ID: 37650745
[TBL] [Abstract] [Full Text] [Related]
5. MicroRNA-143-5p Suppresses ER-Positive breast cancer Development by Targeting Oncogenic hmga2.
Mansoori B; Kiani S; Mezajin AA; Zandi P; Banaie H; Rostamzadeh D; Cho WC; Duijf PHG; Mansoori B; Baradaran B
Clin Breast Cancer; 2023 Oct; 23(7):e480-e490.e3. PubMed ID: 37596147
[TBL] [Abstract] [Full Text] [Related]
6. Construction of the systemic anticancer immune environment in tumour-bearing humanized mouse by using liposome-encapsulated anti-programmed death ligand 1 antibody-conjugated progesterone.
Kametani Y; Ito R; Ohshima S; Manabe Y; Ohno Y; Shimizu T; Yamada S; Katano N; Kirigaya D; Ito K; Matsumoto T; Tsuda B; Kashiwagi H; Goto Y; Yasuda A; Maeki M; Tokeshi M; Seki T; Fukase K; Mikami M; Ando K; Ishimoto H; Shiina T
Front Immunol; 2023; 14():1173728. PubMed ID: 37492571
[TBL] [Abstract] [Full Text] [Related]
7. Coaxial electrostatic spray-based preparation of localization missile liposomes on a microfluidic chip for targeted treatment of triple-negative breast cancer.
Wang Q; Xu W; Li Q; He C; Liu Y; Liu J; Wang R; Wu J; Xiang D; Chen C
Int J Pharm; 2023 Aug; 643():123220. PubMed ID: 37437856
[TBL] [Abstract] [Full Text] [Related]
8. Modulation of tumour hypoxia by ultrasound-responsive microbubbles to enhance the sono-photodynamic therapy effect on triple-negative breast cancer.
Wang H; Shang J; Yang F; Zhang S; Cui J; Hou X; Li Y; Liu W; Shu X; Liu Y; Sun B
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103642. PubMed ID: 37271488
[TBL] [Abstract] [Full Text] [Related]
9. EGFR-Targeted liposomes Combined with Ginsenoside Rh2 Inhibit Triple-Negative breast cancer Growth and Metastasis.
Gu H; Shi R; Xu C; Lv W; Hu X; Xu C; Pan Y; He X; Wu A; Li J
Bioconjug Chem; 2023 Jun; 34(6):1157-1165. PubMed ID: 37235785
[TBL] [Abstract] [Full Text] [Related]
10. Combinatorial Polydopamine-liposome Nanoformulation as an Effective Anti-breast cancer Therapy.
Lu W; Liu W; Hu A; Shen J; Yi H; Cheng Z
Int J Nanomedicine; 2023; 18():861-879. PubMed ID: 36844433
[TBL] [Abstract] [Full Text] [Related]
11. Nitric Oxide-Loaded Bioinspired lipoprotein Normalizes Tumor Vessels To Improve Intratumor Delivery and Chemotherapy of Albumin-Bound Paclitaxel Nanoparticles.
Wu Y; Xie H; Li Y; Bao X; Lu GL; Wen J; Gao Y; Li Y; Zhang Z
Nano Lett; 2023 Feb; 23(3):939-947. PubMed ID: 36701555
[TBL] [Abstract] [Full Text] [Related]
12. Knockdown circTRIM28 enhances tamoxifen sensitivity via the miR-409-3p/hmga2 axis in breast cancer.
Yang S; Zou C; Li Y; Yang X; Liu W; Zhang G; Lu N
Reprod Biol Endocrinol; 2022 Sep; 20(1):146. PubMed ID: 36180890
[TBL] [Abstract] [Full Text] [Related]
13. CD73 downregulation by EGFR-targeted liposomal CD73 siRNA potentiates antitumor effect of liposomal doxorubicin in 4T1 tumor-bearing mice.
Soleimani A; Mirzavi F; Nikoofal-Sahlabadi S; Nikpoor AR; Taghizadeh B; Barati M; Soukhtanloo M; Jaafari MR
Sci Rep; 2022 Jun; 12(1):10423. PubMed ID: 35729230
[TBL] [Abstract] [Full Text] [Related]
14. Combination of tumor vessel normalization and immune checkpoint blockade for breast cancer treatment
Zeng Y; Yu T; Zhang S; Song G; Meng T; Yuan H; Hu F
Biomater Sci; 2022 Jul; 10(15):4140-4155. PubMed ID: 35726757
[TBL] [Abstract] [Full Text] [Related]
15. A DNA damage nanoamplifier for the chemotherapy of triple-negative breast cancer via DNA damage induction and repair blocking.
Huang Y; Dai X; Guan Z; Liu D; Ren L; Chen M; Zeng Z; Jiang J; Luo Y; He Y; Huang M; Zhao C
Int J Pharm; 2022 Jun; 622():121897. PubMed ID: 35690308
[TBL] [Abstract] [Full Text] [Related]
16. Doxorubicin-encapsulated thermosensitive liposome-functionalized photothermal composite scaffolds for synergistic photothermal therapy and chemotherapy.
Chen H; Sun R; Zheng J; Kawazoe N; Yang Y; Chen G
J Mater Chem B; 2022 Jun; 10(25):4771-4782. PubMed ID: 35671131
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic Challenges and Pitfalls of Mammary Pleomorphic Adenoma Illustrated by a Case Report.
Joyon N; Mathieu MC; Rouleau E; Roulot-Paumelle A; Scoazec JY; Suciu V
Int J Surg Pathol; 2023 Jun; 31(4):472-477. PubMed ID: 35635223
[TBL] [Abstract] [Full Text] [Related]
18. DNA-Functionalized liposomes
Zhang N; Shu G; Qiao E; Xu X; Shen L; Lu C; Chen W; Fang S; Yang Y; Song J; Zhao Z; Tu J; Xu M; Chen M; Du Y; Ji J
ACS Appl Mater Interfaces; 2022 May; 14(18):20603-20615. PubMed ID: 35476429
[TBL] [Abstract] [Full Text] [Related]
19. A novel anti-tumor/anti-tumor-associated fibroblast/anti-mPEG tri-specific antibody to maximize the efficacy of mPEGylated nanomedicines against fibroblast-rich solid tumor.
Chen M; Sheu MT; Cheng TL; Roffler SR; Lin SY; Chen YJ; Cheng YA; Cheng JJ; Chang HY; Wu TY; Kao AP; Ho YS; Chuang KH
Biomater Sci; 2021 Dec; 10(1):202-215. PubMed ID: 34826322
[TBL] [Abstract] [Full Text] [Related]
20. Circ-RPPH1 knockdown retards breast cancer progression via miR-328-3p-mediated suppression of hmga2.
Li J; Li Y; Cheng H
Clin Breast Cancer; 2022 Apr; 22(3):e286-e295. PubMed ID: 34593318
[TBL] [Abstract] [Full Text] [Related]
[Next]
